Eyebright Medical Technology (Beijing) Co., Ltd.

SHSE:688050 Stock Report

Market Cap: CN¥15.8b

Eyebright Medical Technology (Beijing) Past Earnings Performance

Past criteria checks 2/6

Eyebright Medical Technology (Beijing) has been growing earnings at an average annual rate of 35.6%, while the Medical Equipment industry saw earnings growing at 7% annually. Revenues have been growing at an average rate of 36.8% per year. Eyebright Medical Technology (Beijing)'s return on equity is 12.6%, and it has net margins of 30.6%.

Key information

35.6%

Earnings growth rate

31.1%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate36.8%
Return on equity12.6%
Net Margin30.6%
Last Earnings Update31 Mar 2024

Recent past performance updates

Eyebright Medical Technology (Beijing)'s (SHSE:688050) Profits May Not Reveal Underlying Issues

Apr 24
Eyebright Medical Technology (Beijing)'s (SHSE:688050) Profits May Not Reveal Underlying Issues

Recent updates

Is Eyebright Medical Technology (Beijing) (SHSE:688050) Using Too Much Debt?

May 13
Is Eyebright Medical Technology (Beijing) (SHSE:688050) Using Too Much Debt?

Eyebright Medical Technology (Beijing)'s (SHSE:688050) Profits May Not Reveal Underlying Issues

Apr 24
Eyebright Medical Technology (Beijing)'s (SHSE:688050) Profits May Not Reveal Underlying Issues

Eyebright Medical Technology (Beijing) Co., Ltd. Just Recorded A 22% Revenue Beat: Here's What Analysts Think

Apr 21
Eyebright Medical Technology (Beijing) Co., Ltd. Just Recorded A 22% Revenue Beat: Here's What Analysts Think

Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

Mar 25
Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) May Have Run Too Fast Too Soon With Recent 26% Price Plummet

A Look At The Fair Value Of Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050)

Mar 18
A Look At The Fair Value Of Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050)

Returns On Capital Are Showing Encouraging Signs At Eyebright Medical Technology (Beijing) (SHSE:688050)

Mar 01
Returns On Capital Are Showing Encouraging Signs At Eyebright Medical Technology (Beijing) (SHSE:688050)

Revenue & Expenses Breakdown

How Eyebright Medical Technology (Beijing) makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:688050 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 241,07232834593
31 Dec 2395130430992
30 Sep 2380628727685
30 Jun 2371327223979
31 Mar 2363825220572
31 Dec 2257923318764
30 Sep 2254922916859
30 Jun 2250020316056
31 Mar 2248019415754
31 Dec 2143317114852
30 Sep 2141616813748
30 Jun 2137615012240
31 Mar 2133112910736
31 Dec 20273979830
30 Sep 20237868626
30 Jun 20204688224
31 Mar 20178538423
31 Dec 19195678222
31 Dec 18127207114
31 Dec 1775-4557

Quality Earnings: 688050 has a high level of non-cash earnings.

Growing Profit Margin: 688050's current net profit margins (30.6%) are lower than last year (39.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688050's earnings have grown significantly by 35.6% per year over the past 5 years.

Accelerating Growth: 688050's earnings growth over the past year (30.1%) is below its 5-year average (35.6% per year).

Earnings vs Industry: 688050 earnings growth over the past year (30.1%) exceeded the Medical Equipment industry -0.5%.


Return on Equity

High ROE: 688050's Return on Equity (12.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.